In addition, pDCs and CD8+ T cells were also found to express HAVCR2 in high expression and CD4+ T cells in lung cancer, while CD4+ T cells in breast cancer and colorectal cancer expressed HAVCR2 significantly lower than CD8+ T cells (Figures 4C, 5C, 6C). This evidence concerns the gene HAVCR2 and lung carcinoma.